10X Genomics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $151,036 | $150,843 | $166,030 | $149,002 |
Gross Profit | 112,497 | 106,178 | 113,045 | 100,307 |
EBITDA | -18,645 | -937 | 63,537 | -15,951 |
EBIT | -12,847 | 51,437 | -28,202 | |
Net Income | -17,931 | -13,470 | -16,252 | -27,472 |
Net Change In Cash | 151,036 | 150,843 | 166,030 | 149,002 |
Free Cash Flow | 15,386 | 24,523 | 39,000 | 42,527 |
Cash | 502,512 | 490,285 | 473,966 | 432,508 |
Basic Shares | 129,984 | 128,291 | 127,078 | 125,502 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $642,823 | $610,785 | $618,727 | $516,409 |
Gross Profit | 443,881 | 414,482 | 409,313 | 396,023 |
EBITDA | 3,909 | -133,988 | -205,111 | -128,489 |
EBIT | -39,907 | -177,696 | -248,730 | -161,495 |
Net Income | -43,544 | -182,627 | -255,099 | -166,000 |
Net Change In Cash | 642,823 | 610,785 | 618,727 | 516,409 |
Cost of Revenue | -368,676 | |||
Free Cash Flow | 130,115 | -5,729 | -64,721 | -165,267 |
Cash | 473,966 | 344,067 | 359,284 | 219,746 |
Basic Shares | 124,749 | 120,451 | 117,165 | 113,858 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.14 |
2026-03-31 | $0.07 |
2025-12-31 | $0.07 |
2025-09-30 | -$0.02 |